Table:
begin	end	state
1	19	cytoplasmic
20	41	transmembrane
42	46	non-cytoplasmic
47	64	transmembrane
65	85	cytoplasmic
86	106	transmembrane
107	124	non-cytoplasmic
125	142	transmembrane
143	153	cytoplasmic
154	176	transmembrane
177	201	non-cytoplasmic
202	221	transmembrane
222	240	cytoplasmic
241	262	transmembrane
263	281	non-cytoplasmic
282	309	transmembrane
310	340	cytoplasmic
341	363	transmembrane
364	369	non-cytoplasmic
370	391	transmembrane
392	412	cytoplasmic
413	432	transmembrane
433	437	non-cytoplasmic
438	455	transmembrane
456	466	cytoplasmic

Input:
>AO353_05965 FitnessBrowser__pseudo3_N2E3:AO353_05965
MADEQLQQGVLKRGLKNRHIQLIALGGAIGTGLFLGSAGVLKSAGPSMILGYAIAGFIAF
LIMRQLGEMIVEEPVAGSFSHFAHNYWGSFAGFLSGWNYWVLYVLVGMAELTAVGKYVQF
WWPEVPTWVSAAVFFVLVNLINTMNVKVFGEMEFWFAIIKVVAIIGMIALGCYMLVSGTG
GPQASVSNLWSHGGFFPNGTNGLLMAMAFIMFSFGGLELVGITAAEASEPRKVIPKAINQ
VVYRVLIFYVGALTVLLSLYPWDQLLQTLGASGDAYSGSPFVQIFALIGSNTAAQILNFV
VLTAALSVYNSGVYCNSRMLYGLAEQGDAPKSLMKLNKQGVPLRALGISALITMLCVVVN
YVAPNEALELLFALVVASLMINWAMISLTHLKFRKAMGQRGIVPGFKAFWSPYTNYLCLA
FMAMIIYVMLLIPGVRASVYAIPVWVLILFVFYRIRVARTRALSVA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server